Literature DB >> 27201349

Persistence And Adherence With Mirabegron, A New Beta-3 Receptor Agonist, Versus Antimuscarinics In Overactive Bladder: Early Experience In Canada.

A Wagg1, B Franks2, B Ramos3, T Berner2.   

Abstract

Year:  2014        PMID： 27201349     DOI： 10.1016/j.jval.2014.08.1336

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  2 in total

Review 1.  Overactive Bladder and the β3-Adrenoceptor Agonists: Current Strategy and Future Prospects.

Authors:  Ilias Giarenis; Dudley Robinson; Linda Cardozo
Journal:  Drugs       Date:  2015-10       Impact factor: 9.546

Review 2.  Mirabegron in the Management of Overactive Bladder Syndrome.

Authors:  Miriam O'Kane; Dudley Robinson; Linda Cardozo; Adrian Wagg; Paul Abrams
Journal:  Int J Womens Health       Date:  2022-09-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.